The fertility sector is likely to present growing opportunities for PE as an emerging, multifaceted industry. By Heather B. Deixler, Tom D. Evans, Elizabeth M. Richards, Linzi Thomas, Eveline Van Keymeulen, David J. Walker, Betty C. Pang, Stuart McRobbie, and Catherine Campbell The global fertility sector, which has grown significantly in recent years as demand … Continue Reading
In Lexology’s Getting the Deal Through: Digital Health 2021 (UK) Latham & Watkins considers the key regulatory and transactional issues faced by market players and practitioners. By Frances Stocks Allen, Oliver Mobasser, Sara Patel, Mihail Krepchev, and Samantha Peacock The UK has an active digital health market comprising both the private and public sectors. Venture … Continue Reading
UK companies interested in producing ventilators and other critical equipment may benefit from regulatory exemptions and use government product specifications. By Frances Stocks Allen and Oliver Mobasser On 16 March 2020, Prime Minister Boris Johnson called on the UK’s leading manufacturing businesses to help the UK step up production of vital medical equipment to combat … Continue Reading
European Commission proposes one-year postponement in light of the COVID-19 crisis. By Frances Stocks Allen and Oliver Mobasser On 25 March 2020, the European Commission announced that it was working on a proposal to postpone the date of application for the new EU Medical Devices Regulation (MDR)[i] for one year, in light of the COVID-19 … Continue Reading
